ERBB2 and breast cancer: Through analysis of gene expression signatures, BC has undergone systematic classification into well-defined molecular subtypes, namely Luminal A, Luminal B [both distinguished by the presence of the Estrogen receptor (ER)], HER2-enriched, and Basal-like.